Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for.
Parola S, Oing C, Rescigno P, Feliciano S, Carlino F, Pompella L, Marretta AL, De Santo I, Viggiani M, Muratore M, Facchini BA, Orefice J, Cioli E, Sparano F, Mallardo D, De Giorgi U, Palmieri G, Ascierto PA, Ottaviano M. Parola S, et al. Among authors: mallardo d. Front Genet. 2024 Nov 29;15:1480417. doi: 10.3389/fgene.2024.1480417. eCollection 2024. Front Genet. 2024. PMID: 39678373 Free PMC article. Review.
ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma.
Mallardo D, Fordellone M, Ottaviano M, Marano G, Vitale MG, Mallardo M, Capasso M, De Cristofaro T, Capone M, Meinardi T, Paone M, Sabatelli P, De Filippi R, Cesano A, Cavalcanti E, Caracò C, Warren S, Budillon A, Simeone E, Ascierto PA. Mallardo D, et al. Int J Mol Sci. 2024 Nov 19;25(22):12439. doi: 10.3390/ijms252212439. Int J Mol Sci. 2024. PMID: 39596506 Free PMC article.
Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients.
Macandog ADG, Catozzi C, Capone M, Nabinejad A, Nanaware PP, Liu S, Vinjamuri S, Stunnenberg JA, Galiè S, Jodice MG, Montani F, Armanini F, Cassano E, Madonna G, Mallardo D, Mazzi B, Pece S, Tagliamonte M, Vanella V, Barberis M, Ferrucci PF, Blank CU, Bouvier M, Andrews MC, Xu X, Santambrogio L, Segata N, Buonaguro L, Cocorocchio E, Ascierto PA, Manzo T, Nezi L. Macandog ADG, et al. Among authors: mallardo d. Cell Host Microbe. 2024 Nov 13;32(11):2004-2018.e9. doi: 10.1016/j.chom.2024.10.006. Epub 2024 Oct 30. Cell Host Microbe. 2024. PMID: 39481388 Free PMC article.
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma.
Ascierto PA, Mandalà M, Ferrucci PF, Guidoboni M, Rutkowski P, Ferraresi V, Arance A, Guida M, Maiello E, Gogas H, Richtig E, Quaglino P, Lebbé C, Helgadottir H, Queirolo P, Spagnolo F, Tucci M, Del Vecchio M, Gonzalez-Cao M, Minisini AM, De Placido S, Sanmamed MF, Casula M, Bulgarelli J, Pisano M, Piccinini C, Piccin L, Cossu A, Mallardo D, Paone M, Vitale MG, Melero I, Grimaldi AM, Giannarelli D, Palmieri G, Dummer R, Sileni VC. Ascierto PA, et al. Among authors: mallardo d. NEJM Evid. 2024 Oct;3(10):EVIDoa2400087. doi: 10.1056/EVIDoa2400087. Epub 2024 Sep 24. NEJM Evid. 2024. PMID: 39315864 Clinical Trial.
A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients.
Mallardo D, Fordellone M, White A, Vowinckel J, Bailey M, Sparano F, Sorrentino A, Mallardo M, Facchini BA, De Filippi R, Ferrara G, Vanella V, Beeler K, Chiodini P, Cesano A, Warren S, Ascierto PA. Mallardo D, et al. Int J Mol Sci. 2024 Aug 28;25(17):9345. doi: 10.3390/ijms25179345. Int J Mol Sci. 2024. PMID: 39273294 Free PMC article.
Long-term complete remission in a patient with high-risk primary mediastinal B-cell lymphoma and iatrogenic symptomatic bradycardia after only two courses of DA-EPOCH-R followed by chemo-free treatment.
Volzone F, Becchimanzi C, Crisci S, De Chiara A, Porto A, Caronna A, Cuccaro A, Sarno S, Mallardo D, Cagini L, De Filippi R, Pinto A. Volzone F, et al. Among authors: mallardo d. Ann Hematol. 2024 Nov;103(11):4759-4764. doi: 10.1007/s00277-024-05994-4. Epub 2024 Sep 12. Ann Hematol. 2024. PMID: 39264432
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma.
Mallardo D, Sparano F, Vitale MG, Trojaniello C, Fordellone M, Cioli E, Esposito A, Festino L, Mallardo M, Vanella V, Facchini BA, De Filippi R, Meinardi P, Ottaviano M, Caracò C, Simeone E, Ascierto PA. Mallardo D, et al. Cancer Immunol Immunother. 2024 Jun 8;73(8):160. doi: 10.1007/s00262-024-03728-z. Cancer Immunol Immunother. 2024. PMID: 38850335 Free PMC article.
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study.
Fletcher K, Cortellini A, Ganta T, Kankaria R, Song H, Ye F, Irlmeier R, Debnath N, Saeed A, Radford M, Alahmadi A, Diamond A, Hoimes C, Presley CJ, Owen DH, Abou Alaiwi S, Nassar AH, Lamberti G, Perrone F, Buti S, Giusti R, Filetti M, Vanella V, Mallardo D, Sussman TA, Galetta D, Kalofonou F, Daniels E, Ascierto PA, Pinato DJ, Nebhan C, Berg S, Choueiri TK, Marron TU, Wang Y, Naqash AR, Johnson DB. Fletcher K, et al. Among authors: mallardo d. Cancer Lett. 2024 Aug 1;596:217001. doi: 10.1016/j.canlet.2024.217001. Epub 2024 Jun 3. Cancer Lett. 2024. PMID: 38838764 Free article.
Editorial: Cancer genomics in the era of precision medicine.
Khan OM, Mallardo D, Decock J. Khan OM, et al. Among authors: mallardo d. Front Genet. 2024 Feb 16;15:1378917. doi: 10.3389/fgene.2024.1378917. eCollection 2024. Front Genet. 2024. PMID: 38435061 Free PMC article. No abstract available.
51 results